Anca is currently using proteogenomics for the discovery of tumor-specific antigens that elicit a protective immune response and can be used as therapeutic cancer vaccines. During her MS she studied the development of T cells in the thymus.
Anca is a PhD candidate in Molecular Biology (Systems Biology) at the University of Montreal, Canada, she completed her MS degree in Molecular Biology (Systems Biology) at University of Montreal, Canada, and holds a BS degree in Biochemistry and Cell Biology from Jacobs University Bremen, Germany.